找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Anti-Inflammatory Drugs in Asthma; Anthony P. Sampson,Martin K. Church Book 1999 Springer Basel AG 1999 Atmen.allergy.asthma.cytokine.rese

[復(fù)制鏈接]
查看: 46743|回復(fù): 44
樓主
發(fā)表于 2025-3-21 20:08:12 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱Anti-Inflammatory Drugs in Asthma
影響因子2023Anthony P. Sampson,Martin K. Church
視頻videohttp://file.papertrans.cn/159/158340/158340.mp4
學(xué)科分類Progress in Inflammation Research
圖書封面Titlebook: Anti-Inflammatory Drugs in Asthma;  Anthony P. Sampson,Martin K. Church Book 1999 Springer Basel AG 1999 Atmen.allergy.asthma.cytokine.rese
影響因子For some years, international guidelines on the management of asthma have stressed the importance of early intervention with anti-inflammatory drugs to prevent acute asthma exacerbations and to avert chronic inflammatory damage to the airway. Introduced by a broad survey of the targets for anti-inflammatory drugs, this book proceeds to bring together the most recent research into the mechanisms and clinical benefits of presently available anti-inflammatory treatments including corticosteroids, cromones, and theophylline. For the first time, these drugs are discussed alongside the newly introduced leukotriene modifier drugs, and in the context of frontline research into anti-inflammatory drugs of the future. Leading authorities in their fields evaluate the prospects of novel anti-IgE agents and cytokine antagonists, and examine recent developments in immunosuppressant compounds, protease inhibitors, and selective phosphodiesterase inhibitors. This book is an up-to-date and authoritative survey which will be invaluable to university and pharmaceutical company researchers working on anti-asthma and anti-allergy drugs and to respiratory physicians keeping abreast of developments in the
Pindex Book 1999
The information of publication is updating

書目名稱Anti-Inflammatory Drugs in Asthma影響因子(影響力)




書目名稱Anti-Inflammatory Drugs in Asthma影響因子(影響力)學(xué)科排名




書目名稱Anti-Inflammatory Drugs in Asthma網(wǎng)絡(luò)公開度




書目名稱Anti-Inflammatory Drugs in Asthma網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Anti-Inflammatory Drugs in Asthma被引頻次




書目名稱Anti-Inflammatory Drugs in Asthma被引頻次學(xué)科排名




書目名稱Anti-Inflammatory Drugs in Asthma年度引用




書目名稱Anti-Inflammatory Drugs in Asthma年度引用學(xué)科排名




書目名稱Anti-Inflammatory Drugs in Asthma讀者反饋




書目名稱Anti-Inflammatory Drugs in Asthma讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:30:25 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:17:32 | 只看該作者
,β2-Agonists, a coupling G-protein and adenylate cyclase, the effector enzyme [3] (Fig. 1). Cyclic AMP is able to modulate a number of processes which are important in governing the contractile state of the cell [4].
地板
發(fā)表于 2025-3-22 07:33:35 | 只看該作者
Anti-IgE Agents,to have a crucial role in the generation and persistence of symptoms in allergic diseases. The development of drugs that interfere with IgE production and function may therefore represent a more specific approach to treat these pathological conditions [1, 2].
5#
發(fā)表于 2025-3-22 10:41:47 | 只看該作者
6#
發(fā)表于 2025-3-22 13:22:36 | 只看該作者
7#
發(fā)表于 2025-3-22 17:20:54 | 只看該作者
8#
發(fā)表于 2025-3-23 01:09:44 | 只看該作者
Marta Mierendorff,Heinrich Tostorphonuclear cells, mast cells, and macrophages are present in an activated state and release proinflammatory mediators, cytokines and growth factors. From inflammation, a process of healing and repair may follow and this has been postulated to lead to remodeling of the airways.
9#
發(fā)表于 2025-3-23 01:25:04 | 只看該作者
https://doi.org/10.1007/978-3-663-02006-6e numerous in the bronchial mucosa [2], submucosa and alveolar walls [3], and are even found free in the lumen [4]. The activation of mast cells by allergen or by other stimuli is associated with the rapid release of a range of potent mediators of inflammation and bronchoconstriction.
10#
發(fā)表于 2025-3-23 08:10:14 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-16 18:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
成都市| 北川| 高州市| 苏尼特右旗| 澄江县| 澄迈县| 肥东县| 涿州市| 海盐县| 潞西市| 沙河市| 苗栗市| 江都市| 昆山市| 宁乡县| 昭觉县| 读书| 阳原县| 铁岭市| 黄浦区| 深州市| 宜州市| 葫芦岛市| 徐州市| 曲水县| 沧源| 喀喇| 印江| 许昌市| 东乡族自治县| 从化市| 阳春市| 滦南县| 孙吴县| 杭锦旗| 莱州市| 永定县| 南和县| 阆中市| 若尔盖县| 福鼎市|